Role of Rho kinases in abnormal and normal hematopoiesis

dc.contributor.authorMali, Raghuveer Singh
dc.contributor.authorKapur, Simryn
dc.contributor.authorKapur, Reuben
dc.contributor.departmentDepartment of Pediatrics, IU School of Medicineen_US
dc.date.accessioned2016-03-28T14:49:50Z
dc.date.available2016-03-28T14:49:50Z
dc.date.issued2014-07
dc.description.abstractPURPOSE OF REVIEW: Rho kinases (ROCKs) are involved in regulating a variety of physiologic functions including cytoskeletal reorganization, migration, adhesion, survival and proliferation. They do so via activating several different downstream substrates such as myosin light chain phosphatase, LIM kinase and ezrin/radixin/moesin proteins. To date, most of the conclusions with regard to the function of ROCKs have involved the use of cell line models, pharmacologic inhibitors and dominant negative approaches. Importantly, the role of ROCK in hematopoiesis or leukemogenesis in the context of whole organism remains poorly understood. RECENT FINDINGS: Recent studies utilizing mice deficient in the expression of ROCK1 have begun to shed some light into the physiologic role(s) of ROCK in both normal and abnormal hematopoiesis. Findings, thus far, suggest that ROCK plays an essential role in regulating growth and survival in different hematopoietic lineages via distinct mechanisms, in part, by utilizing distinct downstream substrates including maintaining the activation of tumor-suppressor genes. SUMMARY: In blood cells, emerging data suggest that ROCK plays an essential role in negatively regulating inflammatory and erythropoietic stress and positively regulates the growth and survival of leukemic cells.en_US
dc.eprint.versionAuthor's manuscripten_US
dc.identifier.citationMali, R. S., Kapur, S., & Kapur, R. (2014). Role of Rho kinases in abnormal and normal hematopoiesis. Current Opinion in Hematology, 21(4), 271–275. http://doi.org/10.1097/MOH.0000000000000056en_US
dc.identifier.issn1531-7048en_US
dc.identifier.urihttps://hdl.handle.net/1805/9060
dc.language.isoen_USen_US
dc.publisherOvid Technologies (Wolters Kluwer) - Lippincott Williams & Wilkinsen_US
dc.relation.isversionof10.1097/MOH.0000000000000056en_US
dc.relation.journalCurrent Opinion in Hematologyen_US
dc.rightsPublisher Policyen_US
dc.sourcePMCen_US
dc.subjectHematologic Diseasesen_US
dc.subjectGeneticsen_US
dc.subjectmetabolismen_US
dc.subjectHematopoiesisen_US
dc.subjectphysiologyen_US
dc.subjectrho-Associated Kinasesen_US
dc.titleRole of Rho kinases in abnormal and normal hematopoiesisen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
nihms672733.pdf
Size:
91.47 KB
Format:
Adobe Portable Document Format
Description:
Author's manuscript
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.88 KB
Format:
Item-specific license agreed upon to submission
Description: